Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood (2022) 139 (19): 2931–2941.

https://doi.org/10.1182/blood.2021012743

Published: 2022

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

Blood (2016) 128 (22): 1124.

https://doi.org/10.1182/blood.V128.22.1124.1124

Published: 2016

Journal Articles

Exploring the Potential of JAK1/2 Inhibitor Ruxolitinib with Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Myelofibrosis: Stage I Results of a Prospective Trial Conducted through the Myeloproliferative Disorders - Research Consortium (MPD-RC)

Blood (2016) 128 (22): 1126.

https://doi.org/10.1182/blood.V128.22.1126.1126

Published: 2016

Journal Articles

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

John O. Mascarenhas, MD MS, Josef T. Prchal, MD, Alessandro Rambaldi, MD, Ruben A. Mesa, MD, Dmitriy Berenzon, MD, Abdulraheem Yacoub, MD, Claire N. Harrison, DM, FRCP, FRCPath, Mary Frances McMullin, MD, Alessandro M. Vannucchi, MD PhD, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Casey L O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, Murat O. Arcasoy, MD, Craig M. Kessler, MD, Rosalind Catchatorian, Damiano Rondelli, MD, Richard T. Silver, MD, Ellen K. Ritchie, MD, Arnon Nagler, Marina Kremyanskaya, MD PhD, Richard F. Schlenk, MD, Rona Singer Weinberg, PhD, Mohamed E Salama, MD, Gianni Tognoni, Giuseppe Prosperini, Alessandra Di Lelio, Eliseo Serone, Lorenzo Marfisi, Jill Kleczko, Heidi E. Kosiorek, MS, Tiziano Barbui, MD, Amylou C. Dueck, PhD, Ronald Hoffman, MD

Blood (2016) 128 (22): 479.

https://doi.org/10.1182/blood.V128.22.479.479

Published: 2016

Journal Articles

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Ruben A. Mesa, MD, Ronald Hoffman, MD, Heidi E. Kosiorek, MS, Josef T. Prchal, MD, Claire N. Harrison, DM, FRCP, FRCPath, Mary Frances McMullin, MD, Abdulraheem Yacoub, MD, Alessandro Rambaldi, MD, Dmitriy Berenzon, MD, Alessandro M. Vannucchi, MD PhD, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Casey L O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, MD, Murat O. Arcasoy, MD, Craig M. Kessler, MD, Rosalind Catchatorian, Damiano Rondelli, MD, Richard T. Silver, MD, Ellen K. Ritchie, MD, Arnon Nagler, Marina Kremyanskaya, MD PhD, Richard F. Schlenk, MD, Rona Singer Weinberg, PhD, Mohamed E Salama, MD, Gianni Tognoni, Giuseppe Prosperini, Alessandra Di Lelio, Eliseo Serone, Lorenzo Marfisi, Alicia Orellana, MD, Tiziano Barbui, MD, Amylou C. Dueck, PhD, John O. Mascarenhas, MD MS

Blood (2016) 128 (22): 4271.

https://doi.org/10.1182/blood.V128.22.4271.4271

Published: 2016

Journal Articles

Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)

Tiziano Barbui, MD, Arianna Masciulli, MSc, PhD, Marco Scarano, Sc.D., Gianni Tognoni, Sara Sisti, Alessandra Di Lelio, Alessandro M. Vannucchi, MD, Mario Cazzola, MD, Alessandro Rambaldi, Konstanze Doehener, Francisco Cervantes, MD PhD, Francesco Passamonti, MD, Andreas Reiter, MD, Steffen Koschmieder, MD, Dietger Niederwieser, MD, Bjorn Andreasson, MD, Peter L. Johansson, MD PhD, Andreas Hochhaus, MD, Claire N. Harrison, DM, FRCP, FRCPath

Blood (2014) 124 (21): 1849.

https://doi.org/10.1182/blood.V124.21.1849.1849

Published: 2014

Journal Articles

Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study).

Blood (2009) 114 (22): 1638.

https://doi.org/10.1182/blood.V114.22.1638.1638

Published: 2009

Journal Articles

Leukocytosis as an Independent Risk Factor for Thrombosis in Polycythemia Vera.

Raffaele Landolfi, MD, Leonardo Di Gennaro, MD, Tiziano Barbui, MD, Valerio De Stefano, MD, Rosamaria Marfisi, MSc, Gianni Tognoni, MD, Francesco Equitani, MD, Guido Finazzi, MD, Roberto Marchioli, MD

Blood (2006) 108 (11): 115.

https://doi.org/10.1182/blood.V108.11.115.115

Published: 2006

Journal Articles

Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera

Raffaele Landolfi, Leonardo Di Gennaro, Tiziano Barbui, Valerio De Stefano, Guido Finazzi, RosaMaria Marfisi, Gianni Tognoni, Roberto Marchioli, for the European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)

Blood (2006) 109 (6): 2446–2452.

https://doi.org/10.1182/blood-2006-08-042515

Published: 2006

Includes: Supplemental data

Journal Articles

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

Guido Finazzi, Vanesa Caruso, Roberto Marchioli, Giovanni Capnist, Teodoro Chisesi, Carlo Finelli, Luigi Gugliotta, Raffaele Landolfi, Jack Kutti, Heinz Gisslinger, Raphael Marilus, Carlo Patrono, Enrico Maria Pogliani, Maria Luigia Randi, Ana Villegas, Gianni Tognoni, Tiziano Barbui, for the ECLAP Investigators

Blood (2005) 105 (7): 2664–2670.

https://doi.org/10.1182/blood-2004-09-3426

Published: 2005

Journal Articles

Prospective Clinical and Epidemiological Evaluation of rHuEPO in the Routine Care of a Network of Hematological Centers.

Tiziano Barbui, MD, Marilena Romero, PharmD, Federica Delaini, BScD, Elisa Sasso, Gianni Tognoni, MD, Mario Cazzola, MD

Blood (2004) 104 (11): 5290.

https://doi.org/10.1182/blood.V104.11.5290.5290

Published: 2004

Journal Articles

Prognosis of Veno-Occlusive Disease after Stem Cell Transplantation in the DF-VOD Trial. On behalf of the DF-VOD Investigators:.

Tiziano Barbui, MD, Vanesa Caruso, MD, Gianni Tognoni, MD, Roberto Marchioli, MD

Blood (2004) 104 (11): 1137.

https://doi.org/10.1182/blood.V104.11.1137.1137

Published: 2004

NARROW

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Safety and Efficacy of Combined Ruxolitinib and Decitabine in Patients with Blast-Phase MPN and Post-MPN AML: Results of a Phase I Study (Myeloproliferative Disorders Research Consortium 109 trial)

Exploring the Potential of JAK1/2 Inhibitor Ruxolitinib with Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Myelofibrosis: Stage I Results of a Prospective Trial Conducted through the Myeloproliferative Disorders - Research Consortium (MPD-RC)

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)

Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study).

Leukocytosis as an Independent Risk Factor for Thrombosis in Polycythemia Vera.

Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

Prospective Clinical and Epidemiological Evaluation of rHuEPO in the Routine Care of a Network of Hematological Centers.

Prognosis of Veno-Occlusive Disease after Stem Cell Transplantation in the DF-VOD Trial. On behalf of the DF-VOD Investigators:.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only